R. Bulusu

Suggest Changes
Learn More
Ten percent to 20% of patients with Hodgkin Lymphoma (HL) are refractory to first-line therapy or relapse. Existing salvage regimens have response rates of 60–85%, considerable toxicity and frequent(More)
  • 1